Alessandro Plebani

ORCID: 0000-0002-2003-3307

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis”.

Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis

Journal of General Virology(2003)10.1099/vir.0.18974-0

N/A

3.5DataRank · unranked

72 citations

Valentina Donati, Stefano Fiore, Jill Marturano, Alessandro Plebani, Paolo Balestri +6 more

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood(2022)10.1182/blood.2022018546

N/A

3.2DataRank · unranked

132 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +17 more

Interim analysis: Open-label extension study of leniolisib for patients with APDS

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.09.032

N/A

1.2DataRank · unranked

40 citations

Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +15 more

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

EMBO Molecular Medicine(2021)10.15252/emmm.202013545

N/A

0.593DataRank · unranked

51 citations

E. Mercuri, Genni Enza Marcovecchio, Maria Carmina Castiello, Giulia Schiroli, Luisa Albano +18 more

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clinical Immunology(2024)10.1016/j.clim.2024.110400

N/A

0DataRank · unranked

16 citations

Anna Šedivá, Virgil A. S. H. Dalm, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +14 more

Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study

Future Rare Diseases(2024)10.1080/23995270.2024.2379239

N/A

0DataRank · unranked

0 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon +6 more

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

Science Immunology(2025)10.1126/sciimmunol.adq1697

N/A

0DataRank · unranked

16 citations

Kerry Dobbs, Ottavia M. Delmonte, Andrew J. Martins, Francesca Pala, Tomoki Kawai +95 more

Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents

Journal of Clinical Investigation(2021)10.1172/jci150143

N/A

0DataRank · unranked

37 citations

David Langlais, Vivien Béziat, Franck Rapaport, Geetha Rao, Tomi Lazarov +42 more